The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges
International Journal of Molecular Sciences · 02.05.2024 · 25 (9) · 4969
DOI: 10.3390/ijms25094969 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.05.2024. Verfasst von Huiting Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, State Key Laboratory of Molecular Vaccinology and Molecula…. Hauptthemen laut MEDLINE: tau Proteins, Protein Aggregation, Pathological. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 241 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Xiamen, China.
Abstract (Originalsprache)
Tau protein misfolding and aggregation are pathological hallmarks of Alzheimer’s disease and over twenty neurodegenerative disorders. However, the molecular mechanisms of tau aggregation in vivo remain incompletely understood. There are two types of tau aggregates in the brain: soluble aggregates (oligomers and protofibrils) and insoluble filaments (fibrils). Compared to filamentous aggregates, soluble aggregates are more toxic and exhibit prion-like transmission, providing seeds for templated misfolding. Curiously, in its native state, tau is a highly soluble, heat-stable protein that does not form fibrils by itself, not even when hyperphosphorylated. In vitro studies have found that negatively charged molecules such as heparin, RNA, or arachidonic acid are generally required to induce tau aggregation. Two recent breakthroughs have provided new insights into tau aggregation mechanisms. First, as an intrinsically disordered protein, tau is found to undergo liquid-liquid phase separation (LLPS) both in vitro and inside cells. Second, cryo-electron microscopy has revealed diverse fibrillar tau conformations associated with different neurodegenerative disorders. Nonetheless, only the fibrillar core is structurally resolved, and the remainder of the protein appears as a “fuzzy coat”. From this review, it appears that further studies are required (1) to clarify the role of LLPS in tau aggregation; (2) to unveil the structural features of soluble tau aggregates; (3) to understand the involvement of fuzzy coat regions in oligomer and fibril formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Int…
ORCID-Profile: Qixu Cai, Hwan-Ching Tai
Förderung
- Natural Science Foundation of Xiamen, China
Zitieren
APA
Zheng, H., Sun, H., Cai, Q., & Tai, H. C. (2024). The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges. International Journal of Molecular Sciences, 25(9), 4969. https://doi.org/10.3390/ijms25094969
Vancouver
Zheng H, Sun H, Cai Q, Tai HC. The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges. International Journal of Molecular Sciences. 2024;25(9):4969. doi:10.3390/ijms25094969
BibTeX
@article{Zheng2024,
author = {Zheng, Huiting and Sun, Huimin and Cai, Qixu and Tai, Hwan-Ching},
title = {The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {9},
pages = {4969},
doi = {10.3390/ijms25094969}
}
EUVIMED